Walleye Trading LLC Innoviva, Inc. Call Options Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $149,554 - $175,968	-9,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $122,764 - $162,055	9,400 New	9,400 $157,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $93,300 - $124,800	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $103,300 - $144,900	10,000 New	10,000 $105,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $137,550 - $156,975	-10,500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $1.67 Million - $2.44 Million	-121,700 Reduced 92.06%	10,500 $147,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $975,804 - $1.28 Million	69,900 Added 112.2%	132,200 $2.31 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $849,149 - $978,110	62,300 New	62,300 $949,000
Q3 2017 Nov 14, 2017	SELL	$12.06 - $14.12 $15,678 - $18,356	-1,300 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,300	1,300 $16,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.